Summary: Researchers have found that retinal photoreceptors run their own intracellular waste-disposal system using lysosomes, overturning a long-held view that these light-sensitive cells depend almost entirely on retinal pigment epithelium (RPE) support cells for degradation of damaged components.
The new study shows photoreceptors contain a self-sufficient quality-control pathway governed by the lipid kinase PIKfyve. In mouse models where PIKfyve was selectively removed, damaged proteins and organelles accumulated inside photoreceptors, triggering progressive cell loss and impaired vision. PIKfyve loss in RPE cells also produced lipid and debris accumulation reminiscent of changes seen in age-related macular degeneration (AMD). These results identify PIKfyve as a critical regulator of retinal health and raise safety questions for systemic drugs that inhibit this enzyme.
Key Facts
- Autonomous photoreceptor recycling: Photoreceptors actively degrade and recycle their own damaged proteins and organelles through internal lysosomal pathways rather than depending solely on RPE-mediated clearance.
- Enzymatic control by PIKfyve: PIKfyve, a lipid kinase, orchestrates endolysosomal trafficking and degradative processes in both photoreceptors and RPE cells.
- Model of retinal degeneration: Removing PIKfyve leads to large-scale waste buildup within photoreceptor cell bodies, progressive retinal degeneration, and permanent reductions in visual function.
- AMD-like pathology in RPE: PIKfyve deficiency in RPE causes accumulation of lipids and cellular debris, mimicking key pathological features of age-related macular degeneration.
- Clinical safety implications: Systemic inhibition of PIKfyve—such as with the investigational drug apilimod—could risk retinal toxicity and visual decline and therefore requires careful vision-focused safety assessment.
Source: University of Oklahoma
Background: For decades, vision science emphasized the role of the RPE in removing photoreceptor waste, especially the daily phagocytosis of shed outer segment tips. While the RPE remains essential for clearing outer segments, researchers at the University of Oklahoma provide strong evidence that photoreceptors themselves run an internal lysosomal recycling system that is essential for their survival and function.
Photoreceptors are among the most metabolically active cells in the body. Constant light-driven signaling generates a heavy burden of damaged proteins and worn cellular parts that must be cleared continuously. The study demonstrates that PIKfyve supports lysosomal activity and protein turnover within photoreceptors. When the enzyme was genetically removed in mice, lysosomal function collapsed, damaged proteins accumulated, and photoreceptors degenerated progressively, producing measurable loss of vision.
The researchers also found that PIKfyve is vital for RPE health. Loss of PIKfyve in RPE cells disrupted phagocytosis and autophagy, leading to accumulation of rhodopsin, lysosomal proteins, and lipid droplets along with metabolic imbalance—changes that resemble hallmark features of age-related macular degeneration. These parallel defects in photoreceptors and RPE link PIKfyve activity directly to overall retinal integrity.
Lead author Raju V. S. Rajala, Ph.D., emphasizes that this work revises the traditional view of retinal waste management: photoreceptors are not passive recipients of RPE support but instead actively perform intracellular cleanup using lysosome-dependent processes controlled by PIKfyve.
Therapeutic implications are twofold. First, enhancing PIKfyve activity or supporting endolysosomal function could become a strategy to slow or prevent degeneration in inherited retinal diseases where clearance of damaged proteins fails. Second, drugs that inhibit PIKfyve systemically—currently under investigation for autoimmune disease, neurodegeneration, cancer, and viral infections—may carry an unintended risk of retinal toxicity. The authors recommend careful ophthalmic monitoring in clinical trials of PIKfyve inhibitors.
Key Questions Answered
A: The study shows photoreceptors maintain an intrinsic lysosomal recycling system that removes misfolded and mislocalized proteins generated during intense phototransduction. This internal clearance complements, rather than replaces, the RPE’s role in engulfing shed outer segment tips.
A: Loss of PIKfyve disrupts endolysosomal trafficking and degradative pathways. Photoreceptors accumulate toxic protein aggregates and vacuoles, leading to cell death and vision loss. RPE cells likewise accumulate lipids and debris, producing AMD-like pathology.
A: Because systemic inhibition of PIKfyve can impair lysosomal function, drugs targeting this enzyme—such as apilimod—could cause off-target retinal damage. The study supports including ocular safety endpoints in trials of PIKfyve inhibitors.
Editorial Notes
- This article was edited by a Neuroscience News editor.
- Journal paper reviewed in full.
- Additional context added by staff.
About this visual neuroscience research news
Author: April Wilkerson
Source: University of Oklahoma
Contact: April Wilkerson – University of Oklahoma
Image: Image credited to Neuroscience News
Original Research (open access):
Title: PIKfyve preserves endolysosomal function in photoreceptors and RPE cells to maintain retinal integrity
Authors: Ammaji Rajala, Larissa J. Trevino, Thamaraiselvi Saravanan, Tyler M. Black, Mohd A. Bhat, Tuan Ngo, Mark Eminhizer, Jianhai Du, Visvanathan Ramamurthy & Raju V. S. Rajala.
DOI: 10.1038/s41419-026-08855-2
Abstract (concise):
Photoreceptors require efficient clearance of outer segment material and mislocalized proteins to preserve cellular health and vision. The study identifies PIKfyve, the kinase that synthesizes PI(3,5)P2, as a central regulator of degradative and metabolic pathways in the retina. PIKfyve is highly expressed in rod photoreceptors; its deletion causes vacuolation, elevated lysosomal markers, thinning of the outer nuclear layer, and loss of rod and cone function. PIKfyve deficiency in the RPE impairs phagocytosis and autophagy, producing accumulation of rhodopsin, lysosomal proteins, and lipid droplets with metabolic imbalance. These findings indicate PIKfyve supports lysosomal function, protein turnover, and metabolic stability in the retina and suggest that preserving or restoring PIKfyve activity may offer therapeutic potential for retinal degenerative diseases. The results also highlight the need for careful ocular safety evaluation of PIKfyve inhibitors in clinical development.